AU1606100A - Compounds and methods for genetic immunization - Google Patents

Compounds and methods for genetic immunization

Info

Publication number
AU1606100A
AU1606100A AU16061/00A AU1606100A AU1606100A AU 1606100 A AU1606100 A AU 1606100A AU 16061/00 A AU16061/00 A AU 16061/00A AU 1606100 A AU1606100 A AU 1606100A AU 1606100 A AU1606100 A AU 1606100A
Authority
AU
Australia
Prior art keywords
compounds
methods
genetic immunization
immunization
genetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16061/00A
Inventor
Barbara A Araneo
John Gebhard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmadigm Inc
Original Assignee
Pharmadigm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmadigm Inc filed Critical Pharmadigm Inc
Publication of AU1606100A publication Critical patent/AU1606100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU16061/00A 1998-11-04 1999-11-03 Compounds and methods for genetic immunization Abandoned AU1606100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18667198A 1998-11-04 1998-11-04
US09186671 1998-11-04
PCT/US1999/025979 WO2000025820A1 (en) 1998-11-04 1999-11-03 Compounds and methods for genetic immunization

Publications (1)

Publication Number Publication Date
AU1606100A true AU1606100A (en) 2000-05-22

Family

ID=22685846

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16061/00A Abandoned AU1606100A (en) 1998-11-04 1999-11-03 Compounds and methods for genetic immunization

Country Status (2)

Country Link
AU (1) AU1606100A (en)
WO (1) WO2000025820A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117904036A (en) * 2024-03-19 2024-04-19 山东第一医科大学(山东省医学科学院) Method for producing snake oil by culturing fat cells of snake

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620896A (en) * 1992-03-23 1997-04-15 University Of Massachusetts Medical Center DNA vaccines against rotavirus infections
US5593972A (en) * 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
US5665383A (en) * 1993-02-22 1997-09-09 Vivorx Pharmaceuticals, Inc. Methods for the preparation of immunostimulating agents for in vivo delivery
US5795872A (en) * 1995-09-19 1998-08-18 Pharmadigm, Inc. DNA construct for immunization
EP0958373A4 (en) * 1996-10-23 2001-11-28 American Home Prod Vaccines

Also Published As

Publication number Publication date
WO2000025820A1 (en) 2000-05-11

Similar Documents

Publication Publication Date Title
AU6111699A (en) Novel method and compounds
AU4635597A (en) Gene synthesis method
AU2726601A (en) Method and system for employment placement
AU9790198A (en) Compounds and methods
AU2913701A (en) System and method for facilitating selection of benefits
AU5430499A (en) Photobioreactor
AU2037400A (en) Software vault
AU6148898A (en) 2-substituted 7-haloindenes and methods for synthesizing
AU5304299A (en) Method for modifying chromosomes
AU5324099A (en) Methods for predicting drug response
AU7989400A (en) Compounds and methods
AU3215500A (en) Compounds and methods
AU1595900A (en) Anti-cancer compounds and methods related thereto
AU3444899A (en) Method for the rapid determination of bacteria
AU2283497A (en) Methods for increasing the maturation of cells
AU3981799A (en) Method for identifying genes
AU1810399A (en) Method for synthesizing
AUPO870297A0 (en) Method
AUPO937097A0 (en) Method
AU7558998A (en) Method for reinforcing
AU1606100A (en) Compounds and methods for genetic immunization
AU1292301A (en) Method for genetic manipulation
AU5552200A (en) Method
AU1834800A (en) Cyanophosphonamides and method for preparation
AU6887198A (en) Improved method for the preparation of benzyluracils

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase